Page 1 of 1

U.S. taxpayers provided substantial funding for the vaccines, in terms of basic infrastructure, OWS itself, and then adv

Posted: Thu May 05, 2022 6:39 am
by answerhappygod
U.S. taxpayers provided substantial funding for the vaccines, in
terms of basic infrastructure,
OWS itself, and then advance purchase commitment contracts. Health
economists provide an
overview here.
In terms of the direct costs of purchasing the developed
vaccines from manufacturers, estimates
indicate that we have paid manufacturers $12 billion for 700
million doses. If delivered prior to
expiration and without wastage, this is enough to vaccinate 350
million people.
Thinking only about these direct costs paid to the
pharmaceutical firms, compare their
revenues against your answer to number 2. What share of the social
value was captured by
the innovating firms? Report as a percent. If easier, you may
instead report as a cost-benefit
per vaccinated person who receives two doses. From a societal
perspective, again thinking
only about this direct spending, were these contracts worthwhile?
State the decision rule
you used in making this assessment.